Study Demonstrates Value of ChromaCode HDPCR(TM) Testing for Tick-Borne Pathogens

CARLSBAD, Calif., Sept. 18, 2019 -- (Healthcare Sales & Marketing Network) -- ChromaCode, Inc., a next-generation molecular diagnostics company using data science to significantly enhance multiplexing capabilities of life science instrumentation, today an... Diagnostics ChromaCode, HDPCR, tick-borne pathogens
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news